Tumor Inflammatory Signature As A Biomarker Of Response To Immunotherapy In Lung Cancer

JOURNAL OF CLINICAL ONCOLOGY(2020)

引用 0|浏览48
暂无评分
摘要
47Background: Tumor Inflammation signatures (TIS) comprising multiple immune genes have been shown to enrich for response to ICI. To study this immune phenotype in a large cohort of clinically eval...
更多
查看译文
关键词
lung cancer,inflammatory signature,immunotherapy,biomarker
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要